KalaCORE

Tackling Visceral Leishmaniasis (VL) in South Asia & East Africa with #UKaid

[KalaCORE @Kala_CORE]

With our programme ending this week – we would like to take the opportunity to thank all our partners and #UKaid @DFID_NTDs for supporting the work in six countries against v #leishmaniasis / #kalaazar. We will continue to post news on publications over the next few months.

[KalaCORE @Kala_CORE]

The fourth and last run of our #MOOC on visceral #leishmaniasis is about to start! Join us https://t.co/JmqfU9vytf #FLcontrolVL

@LSHTM @LSHTM_TEL @FutureLearn supported by #ukaid #openaccess
#EducationForAll

[KalaCORE @Kala_CORE]

In a month’s time starts the next and last run of the #openaccess #MOOC on #FLcontrolVL developed by @LSHTM and KalaCORE partners. Register: https://t.co/JmqfU9dX4F and share with your networks please!
#EducationForAll
#beatNTDs

[KalaCORE @Kala_CORE]

Watch out for KalaCORE poster at #ihea2019 #Basel starting tomorrow. Colleagues from @LSHTM will be sharing findings on the Economic Burden of Visceral #Leishmaniasis in Bangladesh, India, Ethiopia and Sudan. Looking forward to this @healtheconomics #healtheconomics

[KalaCORE @Kala_CORE]

Thank you to all participants to the our #οpenaccess course on the control and elimination visceral #leishmaniasis #kalaazar
#FLcontrolVL !
Note the next run with @LSHTM starts on the 2nd of September.

[KalaCORE @Kala_CORE]

The third run of the #MOOC on visceral #leishmaniasis course has just started! Still time to join in https://t.co/JmqfU9vytf #FLcontrolVL and share your experiences on tackling VL/PKDL @LSHTM @LSHTM_TEL @FutureLearn

[KalaCORE @Kala_CORE]

Counting down the days to the third run of our #οpenaccess course on visceral #leishmaniasis, developed with @LSHTM and VL experts and support from #ukaid Starts this coming Monday - 6th of May, Sign up now https://t.co/JmqfU9dX4F #FLcontrolVL
#beatNTDs #EducationForAll

[KalaCORE @Kala_CORE]

The third run of our #οpenaccess course on visceral #leishmaniasis, developed with @LSHTM and supported by #ukaid Starts on the 6th of May.
Sign up now https://t.co/JmqfU9dX4F #FLcontrolVL

[KalaCORE @Kala_CORE]

Although KalaCORE is now closed, our Twitter account will stay open to share news. Thank you to all our partners for your invaluable collaboration. We wish the best of luck to #ASCEND and #UKaid for their continued support to VL and helping to #beatNTDs .

[albert picado @AlbertPicado]

Multidisciplinary research in action! Epidemiology, molecular biology, immunology, genotyping and many days of field and lab work to identify the “Determinants for progression from asymptomatic infection to symptomatic visceral #leishmaniasis” in India - https://t.co/92ybQxAhr2

[Drugs for Neglected Diseases initiative @DNDi]

We need a rapid, simple & robust #diagnostic test for dermal #leishmaniasis that can be used in endemic countries to enable diagnosis & treatment closer to home. Authors from @FINDdx @WHO @DNDi share a #targetproductprofile for a point-of-care test: https://t.co/q8KzJIm4J6

[ANTI-VeC @AntiVec]

EXCITING NEWS: we have increased the funding - applicants can now apply for grants of up to £10k. This scheme is open call, so you can apply at any point. Funding available for #labexchanges #courses #workshops #workshadowing
More info available here: https://t.co/tIcrEQkAoT

[Drugs for Neglected Diseases initiative @DNDi]

The long-term treatment success of visceral #leishmaniasis patients who also have HIV is complicated by a high relapse rate. A study in Ethiopia tested the safety and effectiveness of secondary prophylaxis to prevent relapses @PLOSNTDs: https://t.co/ytg0ADi5YJ

[Drugs for Neglected Diseases initiative @DNDi]

Interested in presenting your work on diagnosis, treatment, prevention, or elimination of #leishmaniasis?

Submit your abstract by 30 April 2019 for the next LEAP Conference happening in December: https://t.co/OECnzJxmEA

[PLOS NTDs @PLOSNTDs]

New surveillance study of Post Kala-azar Dermal #Leishmaniasis, from Ritika Sengupta and colleagues #PLOSNTDs https://t.co/T1cYn5bCxI

[Drugs for Neglected Diseases initiative @DNDi]

"What kind of girl is this? She is good for nothing."

When #kalaazar survivor Ruby showed symptoms of disfiguring #PDKL, her mother-in-law and husband rejected her. A report on women in Bihar with #leishmaniasis facing stigma and financial difficulty. https://t.co/RugD8PGPES

[MSF International @MSF]

Have you ever heard of #KalaAzar?

This neglected disease cannot be eliminated without addressing its co-infection with #HIV.

What you need to know today:

[LondonNTDResearch @NTDResearch]

New #NTDs research:
Long term prognostics of visceral leishmaniasis in HIV+patients with use of pentamidine, an #ethiopia study
https://t.co/ucZiaesd55
@PLOSNTDs #HIV @MRCTEG_LSHTM

[Emilie Giraud @Emilie__Giraud]

Excited to share my latest paper, published this week in @CommsBio !!!
#sandfly #leishmania
https://t.co/eY1oCK8mzU

[PANDORA-ID-NET @PandoraIDNet]

The closing date for ISID research grants is 1st April 2019. They support the professional development of young investigators working in the field of human infectious diseases by funding pilot research. Please retweet! #publichealth #africanscience

https://t.co/Tk8ztIpLdn